ARISAPH PHARMACEUTICALS INC of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-11-01. The offering totals $20.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| William Bachovchin | Director | Boston, MA |
| Robert Baldini | Director | Madison, NJ |
| Kevin Ferro | Director | Cambridge, MA |
| Antonio Gotto | Director | New York, NY |
| Michael Jaharis | Director | New York, NY |
| Steven Jaharis | Director | Winnetka, IL |
| Christopher Kiritsy | Director | Boston, MA |
| Thomas Koestler | Director | Cambridge, MA |
| Madias Nicolaos | Director | Boston, MA |
| Rex Roten | Director | Clearwater, FL |
| William Bachovchin | Executive Officer | Boston, MA |
| CLAUDE BENEDICT | Executive Officer | SHINJUKU-KU, TOKYO, M0 |
| Christopher Kiritsy | Executive Officer | Boston, MA |
| Joseph Suarez | Executive Officer | Boston, MA |